SRI 37892

TargetMol
Product Code: TAR-T9662
Supplier: TargetMol
CodeSizePrice
TAR-T9662-1mg1mg£389.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9662-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9662-1mL1 mL * 10 mM (in DMSO)£978.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9662-10mg10mg£1,107.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9662-25mg25mg£1,637.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9662-50mg50mg£2,175.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9662-100mg100mg£2,906.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C

Images

1 / 1

Further Information

Bioactivity:
SRI 37892 is a Fzd7 inhibitor with potent activities against Wnt/β-catenin signaling and cancer cell viability.
CAS:
1030769-75-5
Molecular Weight:
465.53
Pathway:
Stem Cells|Cytoskeletal Signaling
Purity:
0.9892
SMILES:
O=C(NC1=NC(=CS1)C=2C=CC=3NC(=O)CCC3C2)C4=CC=C(C=C4)N5C=NC=6C=CC=CC65
Target:
Wnt/beta-catenin

References

Zhang W, et al. Discovery of novel frizzled-7 inhibitors by targeting the receptor's transmembrane domain. Oncotarget. 2017 Sep 6;8(53):91459-91470.